Yang Guanghua Nano is real. Dr. Yang Guanghua led the team to invent a brand-new treatment technology for malignant solid tumors-a new nano-particle targeted nuclide (ImDendrim) treatment technology (referred to as "nano-gun" technology), which can target and specifically kill tumor cells. This technology patent has been authorized by the international PCT worldwide. Because of the effectiveness, safety and originality of this technology, it was rated as the most revolutionary patent technology for cancer treatment by the French Cancer Center. At present, the project has not been vigorously promoted, and the preliminary work of the project is under way. Yang Guanghua graduated from Royal Navarra Medical College in 2006, majoring in gene therapy. The research direction is mainly gene drug research using genes and stem cells to treat AIDS. He worked in the French National Academy of Sciences and the French National Institute of Health. In 2007, Bion Biomedical Technology Co., Ltd., the first domestic gene carrier technology service company, was established in Shanghai, and began to develop new technologies for tumor treatment, becoming one of the youngest national specially invited experts in the biomedical field in China.